RyboDyn, Inc., a biotechnology company decoding the dark proteome with an AI-powered sequencing and discovery platform, today announced a $1.3 million award from the U.S. Department of War (DOW) to ...

High-resolution spatial transcriptomics and imaging-based technologies are now generating large-scale, multi-dimensional datasets that are beginning to reshape how we understand tissue organisation, ...

Biomedical engineer Sangeeta Bhatia reflects on her journey in pioneering liver research, developing advanced diagnostics, ...

Caris Life Sciences® , a leading patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the commercial launch of Caris Detecttm, a groundbreaking ...

See what bills become law in the Magnolia State on July 1. Each year, Mississippi lawmakers file thousands of bills requiring ...

Researchers at the Icahn School of Medicine at Mount Sinai and the Lieber Institute for Brain Development have identified ...

A research team has mapped how 5-methylcytosine (m5C), an RNA methylation mark, changes in tomato fruits after infection by ...

Caris Life Sciences® (NASDAQ: CAI), a leading patient-centric next-generation AI TechBio company and precision medicine pioneer, today announced the dual listing of its common stock on NYSE Texas ...

Immunology researchers are working to understand complex adaptive immune responses, but meaningful signals are often rare, transient, or difficult to capture across large, sample-limited studies.

Detailed price information for 10X Genomics Inc (TXG-Q) from The Globe and Mail including charting and trades.

Until now, studying the genetic processes in cells required destroying them - making it impossible to observe these processes over extended periods of time. A team from the Technical University of ...